US2019142808A1PendingUtilityA1

Sustained-release preparation composition for animals

Assignee: DS PHARMA ANIMAL HEALTH CO LTDPriority: Jun 9, 2016Filed: Jun 8, 2017Published: May 16, 2019
Est. expiryJun 9, 2036(~9.9 yrs left)· nominal 20-yr term from priority
A61K 47/26A61P 25/08A61K 47/44A61K 47/14A61K 9/2054A61K 47/12A61K 31/423A61K 47/36A61K 9/0002A61K 47/38A61K 9/2018
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a sustained-release pharmaceutical composition intended for animal use, which comprises a drug, a sugar, a wax, and a water-soluble polymer.

Claims

exact text as granted — not AI-modified
1 - 10 . (canceled) 
     
     
         11 . A sustained-release composition intended for animal use, comprising (i) zonisamide, (ii) a sugar, (iii) a wax, and (iv) a water-soluble polymer, wherein
 (i) the content of zonisamide is 10 wt %-90 wt %,   (ii) the sugar is one or more selected from isomalt, mannitol, lactose, sucrose, glucose, and sorbitol, and the content of the sugar is 5 wt %-90 wt %,   (iii) the wax is one or more selected from hydrogenated castor oil, hydrogenated rapeseed oil, carnauba wax, stearic acid, and sodium stearyl fumarate, and the content of the wax is 0.5 wt %-70 wt %,   (iv) the water-soluble polymer is one or more selected from gum arabic, xanthane gum, hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC), and methylcellulose (MC), the content of the water-soluble polymer is 2 wt %-80 wt %, and   the animal belongs to Carnivora.   
     
     
         12 . The sustained-release composition of  claim 11 , wherein (i) the content of the zonisamide is 15 wt %-80 wt %, (ii) the content of the sugar is 10 wt %-80 wt %, (iii) the content of the wax is 1 wt %-60 wt %, and (iv) the content of the water-soluble polymer is 4 wt %-70 wt %. 
     
     
         13 . The sustained-release composition of  claim 11 , wherein (i) the content of the zonisamide is 20 wt %-70 wt %, (ii) the content of the sugar is 15 wt %-70 wt %, (iii) the content of the wax is 1.5 wt %-50 wt %, and (iv) the content of the water-soluble polymer is 6 wt %-60 wt %. 
     
     
         14 . The sustained-release composition of  claim 11 , wherein the animal is dogs or cats. 
     
     
         15 . The sustained-release composition of  claim 11 , whose formulation is a tablet. 
     
     
         16 . The sustained-release composition of  claim 11 , wherein the sugar is isomalt. 
     
     
         17 . The sustained-release composition of  claim 11 , wherein the water-soluble polymer is gum arabic and/or hydroxypropylcellulose (HPC).

Join the waitlist — get patent alerts

Track US2019142808A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.